Skip to main content

Review board that approved fake study calls it quits

 |  By HealthLeaders Media Staff  
   April 23, 2009

A Colorado company that approved a fake medical study in a congressional sting operation said it will close, according to the Wall Street Journal. Coast IRB said the disclosure of the sting and an April 14 warning letter from the Food and Drug Administration describing the company's violations led several high-profile customers to pull their business. As a result, "Coast IRB's owners decided, through counsel, to cease future company operations," a company statement said.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.